Primidone: Packaging and name change
From May 2022 the labelling on primidone packs will look different, but the tablets are exactly the same.
What's changing?
From May 2022 the labelling on primidone packs will look different and the brand name will change from ‘Apo-Primidone’ to ‘Primidone’.
The engraving on the tablet will change but it's the same tablet.
What's staying the same?
‘Primidone’ tablets are the same as ‘Apo-Primidone’ tablets. They are made in the same place and have the same ingredients.
The tablets will still come in a 100 tablet pack.
Primidone is Medsafe-approved and remains fully funded with no restrictions.
Why is this happening?
The previous supplier, Apotex, has left the New Zealand market. We have contracted with Clinect to continue supplying the same primidone tablets to New Zealand.
Key dates
- 1 May 2022: ‘Primidone Clinect’ brand is fully funded and listed on the Schedule (pharmacode 2621746).
- 1 January 2023: The ‘Apo-Primidone’ brand will be delisted from the Schedule and no longer funded (pharmacode 2049015).
Schedule listing for primidone(external link)
Who to contact
If you have any questions or concerns about this change, talk with your doctor, nurse or pharmacist.
You can also get more information from us at enquiry@pharmac.govt.nz or 0800 660 050